Kronos Bio, Inc.
KRON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $57,067 | $72,180 | $91,046 | $744,101 |
| - Cash | $84,571 | $64,326 | $75,973 | $339,509 |
| + Debt | $24,900 | $28,272 | $31,091 | $33,762 |
| Enterprise Value | -$2,605 | $36,126 | $46,164 | $438,354 |
| Revenue | $9,848 | $6,288 | $0 | $0 |
| % Growth | 56.6% | – | – | – |
| Gross Profit | $9,848 | $6,288 | -$4,463 | -$4,081 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$61,716 | -$119,694 | -$128,741 | -$146,997 |
| % Margin | -626.7% | -1,903.5% | – | – |
| Net Income | -$86,079 | -$112,673 | -$129,293 | -$149,101 |
| % Margin | -874.1% | -1,791.9% | – | – |
| EPS Diluted | -1.43 | -1.95 | -2.3 | -2.72 |
| % Growth | 26.7% | 15.2% | 15.4% | – |
| Operating Cash Flow | -$65,435 | -$78,582 | -$90,926 | -$117,924 |
| Capital Expenditures | -$4 | -$679 | -$577 | -$4,260 |
| Free Cash Flow | -$65,439 | -$79,261 | -$91,503 | -$122,184 |